Publications

Using water-adjusted person years to quantify the value of being water secure for an individual's quality of life.

ROSS, I;

2022

Water Research, (2022).227, 10.1016/j.watres.2022.119327.

TB-PRACTECAL: the economic case for 24-week BPaL-based treatments for drug-resistant TB.

SWEENEY, S; Laurence, Y; Berry, C; Kazounis, E; Motta, I; DODD, M; FIELDING, K; Nyang'wa, B;

2022

(2022).

Health Economic Evaluation Using Markov Models in R for Microsoft Excel Users: A Tutorial.

Green, N; Lamrock, F; NAYLOR, N; Williams, J; BRIGGS, A;

2022

PharmacoEconomics, (2022).41 1 10.1007/s40273-022-01199-7.

Cost-Effectiveness of Dapagliflozin as a Treatment for Chronic Kidney Disease: A Health-Economic Analysis of DAPA-CKD.

McEwan, P; Darlington, O; Miller, R; McMurray, JJ V; Wheeler, DC; Heerspink, HJ L; BRIGGS, A; Bergenheim, K; Garcia Sanchez, JJ;

2022

Clinical journal of the American Society of Nephrology, (2022).17 12 10.2215/CJN.03790322.

Cost of TB services: approach and summary findings of a multi-country study (Value TB).

SWEENEY, S; LAURENCE, YV; Cunnama, L; Gomez, GB; Garcia-Baena, I; Bhide, P; Capeding, TJ; Chatterjee, S; Chikovani, I; Eyob, H; Kairu, A; Terefe, MM; Shengelia, N; Toshniwal, M; Saadi, N; Bergren, E; VASSALL, A;

2022

International journal of tuberculosis and lung disease, (2022).26 11 10.5588/ijtld.22.0096.

Considering equity in priority setting using transmission models: Recommendations and data needs.

Quaife, M; MEDLEY, GF; JIT, M; Drake, T; Asaria, M; Van Baal, P; Baltussen, R; Bollinger, L; BOZZANI, F; BRADY, O; Broekhuizen, H; Chalkidou, K; Chi, Y-L; Dowdy, DW; Griffin, S; Haghparast-Bidgoli, H; Hallett, T; Hauck, K; Hollingsworth, TD; MCQUAID, CF; Menzies, NA; Merritt, MW; Mirelman, A; Morton, A; RUIZ, FJ; ... Gomez, GB.

2022

Epidemics, (2022).41, 10.1016/j.epidem.2022.100648.

Optimal Respiratory Syncytial Virus intervention programmes using Nirsevimab in England and Wales.

HODGSON, D; Koltai, M; KRAUER, F; FLASCHE, S; JIT, M; ATKINS, KE;

2022

Vaccine, (2022).40 49 10.1016/j.vaccine.2022.10.041.

Financing primary health care in low- and middle-income countries: A research and policy agenda.

HANSON, K; BALABANOVA, D; Brikci, N; ERLANGGA, D; POWELL-JACKSON, T;

2022

Journal of health services research & policy, (2022).28 1 10.1177/13558196221135741.

A guideline for economic evaluations of vaccines and immunization programs in China.

Fang, H; Chen, C; Fang, Y; He, X; Hou, Z; Jiang, M; Jiang, Y; Li, S; LIU, Y; Sui, B; Sun, Q; Wu, J; Xu, T; Yang, J; Yin, Z; Ying, X; Yuan, B; Zheng, H; Zheng, Y;

2022

Human vaccines & immunotherapeutics, (2022).18 6 10.1080/21645515.2022.2132802.

'I went there in an effort to help the child, but you can see there is corruption in the world': Adults' conceptualisations and enactments of child protection in schools in a challenging context.

TURNER, E; Nyakuwa, R; Nhenga-Chakarisa, T; Muchemwa Nherera, C; Nyadombo, AT; Mgugu, D; Trigg, C; FABBRI, C; Rank, S; DEVRIES, K;

2022

PLoS One, (2022).17 10 10.1371/journal.pone.0275918.